An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn MoreAbout mild for Patients
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAbout mild for Healthcare Professionals
If you didn’t make it to #ASPN2024, you might’ve missed the latest MOTION Study data released by Dr. Tim Deer (@timdeer30a).
The new 3-year follow-up results of patients treated with Mild + conventional medical management provide additional evidence for the durability and safety of Mild as a first-line treatment in a real world setting for symptomatic LSS secondary to hypertrophic ligamentum flavum.*
*Check out Dr. Deer’s insights on the study and view the clinical data at the 🔗 link in bio.
Another fantastic society meeting for the history books!
Thank you to the American Society of Pain and Neuroscience (@aspn_painneuro) and all our Mild providers for making #ASPN2024 an interesting and educational meeting. We`re particularly thankful for all the moving Mild stories you shared with us and the new data we got to explore from the MOTION Study.
If you missed out on ASPN, visit the 🔗 link in bio for event highlights!
In a new case study from Dr. Youssef Josephson (@doctorjoedo) with Modern Spine and Pain, we’re sharing how the Mild Procedure helped an 87-year-old female patient with lumbar spinal stenosis patient (#LSS) avoid major surgery while improving quality of life, regaining functional ability, and discontinuing use of pain medication.
Read Dr. Josephson’s case study at the 🔗 link in bio.
Our CEO, Eric Wichems, had the honor of joining an #ASPN2024 panel discussion on “Explosive Innovation and Limited Patient Access in Minimally Invasive Spine: Fixing a Broken System.”
Thank you to the American Society of Pain and Neuroscience (@aspn_painneuro) for hosting this important talk and their advocacy for improved patient access!
Interested in resources to help increase patient access to Mild? Visit the 🔗 link in bio.
Thank you to everyone who attended our #ASPN2024 symposium on “A New Era for IPM: Elevate Your Practice & Your Community Through Mild.”
A special thanks to our fantastic panel of speakers: Dr. David M. Dickerson (@daviddickersonmd), Advanced Practice Provider Zohra Hussaini, Dr. Rebecca Sanders, and Dr. Peter Pryzbylkowski (@drpryz). We’re grateful to their dedication to the IPM community. We know that their insights and experiences will help many providers grow their practices, expand patient access, and enhance patient experience.
Click the 🔗 link in bio to stay up to date on Mild news and our ASPN 2024 activities.
#ASPN2024 is off to a great start, and we’re already hearing lots of wonderful success stories from providers! There’s nothing we love more than learning how your patients and your practice are thriving because of Mild.
Do you have a story to tell about how Mild is elevating your patients, practice, or community? Stop by our booth to record your story! We’ll be sharing the recordings on our social media channels soon.
Click the 🔗 link in bio to learn more about our program at ASPN!
We’re excited to check out new data at #ASPN2024, including “MOTION Study: Two-Year Follow-Up of Crossover Patients Treated with the Mild Procedure” by Dr. Sherif Costandi.
Swing by our booth to discuss the study and the Mild Procedure for #LSS. Not going to ASPN? Click the 🔗 link in bio for more info!
#ASPN2024 is right around the corner! Don’t forget to attend our lunch symposium on “A New Era for IPM: Elevate Your Practice & Your Community Through Mild.”
This interactive discussion with Dr. David Dickerson (@daviddickersonmd), Advanced Practice Provider Zohra Hussaini, Dr. Peter Pryzbylkowski (@drpryz), and Dr. Rebecca Sanders will explore how they’ve implemented the Mild Procedure to help #LSS patients reclaim quality of life and mobility while growing their own practices and elevating IPM care.
Need more info? Check out our ASPN program at the 🔗 link in bio.
Patient word of mouth can make a big impact! Dr. Aileen Padilla (@painlesspadilla) found her practice started to grow when patients shared their Mild experiences with one another:
“Their neighbors see them walking around, and notice that hey, they’re standing up straighter. It seems like they’re going for a walk every day. And then they ask them, ‘well, what did you do?’”
Visit the 🔗 link in bio to discover how Mild for #LSS can help grow & differentiate your practice.
Dr. Brian Durkin (@dr_durkin_interventional_pain) calls the Mild Procedure “one of the first really big breakthroughs in the treatment of lumbar spinal stenosis (#LSS).”
Now, he and his practice can offer Mild to bridge the gap between injections and surgery, especially for elderly patients who tend to have higher surgical risk.
Go to the 🔗 link in bio to find out how we’re expanding access to Mild & how you can help.
We’re very excited to host a symposium discussion at #ASPN2024 with Dr. David Dickerson (@daviddickersonmd), Advanced Practice Provider Zohra Hussaini, Dr. Peter Pryzbylkowski (@drpryz), and Dr. Rebecca Sanders on “A New Era for IPM: Elevate Your Practice & Your Community Through Mild.”
Our panel of speakers will share how they’ve:
▶️ implemented the Mild Procedure for #LSS to help patients reclaim quality of life through mobility and lasting relief.
▶️ integrated Mild into care pathways while navigating busy OR schedules.
▶️ collaborated with APPs and surgeons to identify and educate patients.
▶️ positioned their practice as the go-to pain management provider in their communities.
To get more info on the program, visit the 🔗 link in bio.
At #ASPN2024, we’re celebrating over 100,000 patients treated with the Mild Procedure for lumbar spinal stenosis (#LSS)!
To honor this milestone, join our lunch symposium on Friday, 7/12 & stop by our booth to learn how Dr. David Dickerson (@davedickersonmd) and leading Mild providers are elevating their practice and community through Mild.
Go to the 🔗 link in bio for more info on our ASPN program.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
The mild® Procedure is a minimally invasive treatment for lumbar spinal stenosis. As with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary here.
Deer TR, Grider JS, Pope JE, et al. Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2022;15:1325-1354. Published 2022 May 5. doi:10.2147/JPR.S355285.
